Clinical Trial Update: Evaluation of the Role of Adalimumab on Extraarticular Manifestation - Bone Metabolism and Bone Mineral Density in Patients With Active Rheumatoid Arthritis

View source ↗

Summary

A completed trial assessed the impact of adalimumab on extraarticular bone health (bone metabolism and bone mineral density) in patients with active rheumatoid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Rheumatoid Arthritis, Osteoporosis | Status: COMPLETED | Results posted: 2015-05-29